Industry Trend Analysis
The global craniomaxillofacial devices market is expected to be around $3 billion by 2025. Craniomaxillofacial (CMF) is a discipline of orthopedic surgery that deals with all the aspects related to facial and skull disorders. Craniomaxillofacial procedures are usually performed to treat severe injuries to the facial and cranial bones. The global craniomaxillofacial devices market is majorly driven by factors such as rising incidence of sports injuries leading to facial injuries and fractures along with increasing demand for minimally invasive surgical procedures. According to Stanford Children’s Health, in the U.S. alone, each year about 30 million children and teenagers take part in some form of organized sport where more than 3.5 million sports injuries are reported. Increasing incidence of accidents worldwide is another factor contributing to the rising demand for reconstructive surgeries. Moreover, technological advancements in minimally invasive surgical devices and procedures are expected to further fuel the growth of craniomaxillofacial devices market during the analysis period. However, factors such as high cost of craniomaxillofacial surgeries and unfavorable reimbursement policies are expected to restrain the market growth during the forecast period.
Product Outlook and Trend Analysis
CMF plate and screw fixation segment dominated the product market in 2016 owing to its extensive usage in different surgical procedures such as orthognathic surgery, deformity correction, pediatric surgeries and tumor removal. Temporomandibular joint (TMJ) replacement segment is expected to exhibit fastest growth during the forecast period owing to rise in number of cosmetic surgeries such as jaw replacement and chin augmentation.
Material Outlook and Trend Analysis
Metal segment dominated the materials market in 2016 owing to their associated benefits such as providing rigid support to the fractures, being less corrosive and being cheaper than other bioabsorbable materials. They are used in craniomaxillofacial procedures as they physiologically support the fractures. Bioabsorbable materials segment is expected to exhibit lucrative growth during the forecast period since their usage eliminates the need of a second surgery, usually required in case of metallic implants as these are easily assimilated in the body.
Application Outlook and Trend Analysis
Neurosurgery and ENT segment held the largest share of the applications market in 2016 due to the rising incidence of spine related disorders which require cerebrospinal fluid management during surgery. Applications of craniomaxillofacial procedures in neurology usually include otolaryngology procedures and skull surgeries. Craniomaxillofacial devices are used for treatment of neurovascular diseases, neuro-oncology, dura mater repair, spinal disorders and other neurosurgical procedures.
Regional Outlook and Trend Analysis
North America dominated the overall craniomaxillofacial devices market in 2016 owing to rising incidence of facial fractures and facial deformities. With the presence of advanced healthcare infrastructure and rapidly increasing urbanization in the region, the North American craniomaxillofacial devices market will witness robust growth over the forecast period. Asia-Pacific market will experience rapid growth over coming few years with presence of highly untapped opportunities due to unmet medical needs. Favorable economic growth leading to increasing disposable income in emerging nations will largely contribute to the Asia-Pacific craniomaxillofacial devices market during the forecast period.
The major players in the global craniomaxillofacial devices market focus on product development and geographic expansion to increase their reach to new marketplaces. For instance, in January 2017, OssDsign AB, a Swedish company involved in design, development and distribution of next generation cranial and facial reconstruction implants, obtained the FDA 510(k) approval for its OSSDSIGN Cranial PSI in the U.S. OSSDSIGN Cranial is a medical implant used for reconstruction of cranial defects in a procedure called cranioplasty.
Some of the major players operating in the global craniomaxillofacial devices market are Stryker Corporation, KLS Martin L.P., Zimmer Biomet Holdings, Inc., Medtronic plc, DePuy Synthes (a subsidiary of Johnson & Johnson Services, Inc.), B. Braun Melsungen AG, TMJ Concepts, OsteoMed, and Medartis AG.
With increasing demand for low cost and effective craniomaxillofacial devices from the patient community, the future opportunities lie in development of such devices with enhanced minimally invasive capabilities. Such undertakings will favorably contribute the market growth in coming years. Moreover, with expanding distribution systems in emerging markets, leading players in the industry can enhance their global presence leading to impressive growth of the global craniomaxillofacial devices market.
Craniomaxillofacial Devices Market Segmentation
Cranial Flap Fixation Devices
Temporomandibular Joint Replacement Devices
Bone Graft Substitutes
CMF Plate and Screw Fixation
Neurosurgery & ENT
Orthognathic and Dental Surgery
Rest of Europe
Rest of Asia Pacific
Rest of the World
United Arab Emirates
Some of the key questions answered by the report are:
What was the market size in 2016 and forecast from 2017 to 2025?
What will be the industry market growth from 2017 to 2025?
What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
What are the major segments leading the market growth and why?
Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?